Harmony Biosciences

Harmony Biosciences Announces Inclusion Of WAKIX® (pitolisant) In American Academy Of Sleep Medicine’s Updated Clinical Practice Guideline

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced that the American Academy of Sleep Medicine (AASM) has published an updated clinical practice guideline which includes WAKIX® (pitolisant) …

Harmony Biosciences Announces Inclusion Of WAKIX® (pitolisant) In American Academy Of Sleep Medicine’s Updated Clinical Practice Guideline Read More

Harmony Biosciences

Harmony Biosciences Acquires Asset with Novel Mechanism of Action for the Potential Treatment of Narcolepsy and Other Rare Neurological Diseases

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) this week announced the acquisition of HBS-102 (formerly CSTI-100), a potential first-in-class molecule with a novel mechanism of action, from …

Harmony Biosciences Acquires Asset with Novel Mechanism of Action for the Potential Treatment of Narcolepsy and Other Rare Neurological Diseases Read More